The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 16,601–16,700 of 31,469
Shimabukuro, M., Saito, T., Higa, T., Nakamura, K., Masuzaki, H., Sata, M., & the Fukuoka diabetologists group (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0325 · Cited by 17
de Luis, D. A., Izaola, O., Alonso, M. G., Aller, R., Cabezas, G., & de la Fuente, B. (2012) · PubMed · Cited by 17
Ay, L., Thaler, J., Brix, J., Schernthaner, G.-H., Ay, C., Pabinger, I., & Schernthaner, G.-H. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.246 · Cited by 17
Chronic anovulation and the polycystic ovary syndrome
KASE, N. G. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.012 · Cited by 16
Szosland, K., & Lewiñski, A. (2015) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2015.10.007 · Cited by 17
Seo, M., Lee, Y.-S., & Moon, S. (2016) · Diabetic Medicine · doi:10.1111/dme.13096 · Cited by 17
Seravalle, G., Brambilla, G., Pizzala, D. P., Casati, A., Riva, M., Cuspidi, C., Bombelli, M., Mancia, G., & Grassi, G. M. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.01.006 · Cited by 17
Rech, C. M. Z., Clapauch, R., de Souza, M. D. G. C., & Bouskela, E. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0878 · Cited by 18
Bigoloni, A., Gianotti, N., Spagnuolo, V., et al. (2012) · AIDS · doi:10.1097/qad.0b013e32835705dd · Cited by 17
Senior, P. A., Koh, A., Yau, J., Imes, S., Dinyari, P., Malcolm, A. J., Light, P. E., & Shapiro, A. M. J. (2016) · Diabetic Medicine · doi:10.1111/dme.13131 · Cited by 16
Se, C., Chuah, K.-A., Mishra, A., Ratnam, W., & Karupaiah, T. (2016) · Nutrients · doi:10.3390/nu8050308 · Cited by 22
Žák, A., Burda, M., Vecka, M., et al. (2014) · Physiological Research · doi:10.33549/physiolres.932868 · Cited by 17
Liang, J., Sun, Y., Liu, X., Zhu, Y., Pei, Y., Wang, Y., Qiu, Q., Yang, M., & Qi, L. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.06.006 · Cited by 17
Obese type 2 diabetes mellitus patients have higher serum vaspin concentrations
Dai, R., Dong, Z., Yu, Q., et al. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12365 · Cited by 17
Jung, S. Y., Sobel, E. M., Papp, J. C., Crandall, C. J., Fu, A., & Zhang, Z. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21991 · Cited by 18
Lane‐Cordova, A. D., Witmer, J. R., Dubishar, K., DuBose, L. E., Chenard, C. A., Siefers, K., Myers, J. E., Wegman‐Points, L., & Pierce, G. L. (2016) · Vascular Medicine · doi:10.1177/1358863x16656063 · Cited by 17
Paganella, M. P., Cohen, R., Harris, D. R., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001163 · Cited by 17
Oliveira, L. G., Moreno, L. G., Melo, D. D. S., Costa-Pereira, L. V., Carvalho, M. M. D. F., Evangelista-Silva, P. H., Alves, A. M., Magalhães, F. D. C., Dias‐Peixoto, M. F., & Esteves, E. A. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0422-9 · Cited by 18
Hafizur, R. M., Momin, S., & Fatima, N. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1743-y · Cited by 17
Stawerska, R., Smyczyńska, J., Hilczer, M., & Lewiñski, A. (2017) · International Journal of Endocrinology · doi:10.1155/2017/5713249 · Cited by 17
Barceló, A., Morell‐García, D., Salord, N., Esquinas, C., Pérez, G., Pérez, A., Monasterio, C., Gasa, M., Fortuna, A. M., Montserrat, J. M., et al. (2017) · Journal of Sleep Research · doi:10.1111/jsr.12551 · Cited by 18
Mu, S., Liu, J., Guo, W., Zhang, S., Xiao, X., Wang, Z., & Zhang, J. (2017) · Obesity Facts · doi:10.1159/000470912 · Cited by 17
Fu, Y., Xu, H., Xia, Y., Qian, Y., Li, X., Zou, J., Wang, Y., Meng, L., Tang, X., Zhu, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19113 · Cited by 18
Circulating branched-chain amino acids in children with obstructive sleep apnea
Barceló, A., Bauçà, J. M., Zarza, J. A. P., et al. (2017) · Pediatric Pulmonology · doi:10.1002/ppul.23753 · Cited by 17
Reutrakul, S., Sumritsopak, R., Saetung, S., Chanprasertyothin, S., Chailurkit, L., & Anothaisintawee, T. (2017) · Neurobiology of Sleep and Circadian Rhythms · doi:10.1016/j.nbscr.2017.06.001 · Cited by 17
Associations of Physical Activity Intensities with Markers of Insulin Sensitivity
Jelleyman, C., Edwardson, C. L., Henson, J. J., Gray, L. J., Rowlands, A. V., Khunti, K., Davies, M. J., & Yates, T. E. (2017) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001381 · Cited by 18
Paquette, M., Saavedra, Y. G. L., Chamberland, A., et al. (2017) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0027 · Cited by 17
Body composition and metabolic profile in adults with vitamin D deficiency
Rocha, L. M., Baldan, D. C. S., de Souza, A. L., Chaim, É. A., Pavin, E. J., & Alegre, S. M. (2017) · Revista de Nutrição · doi:10.1590/1678-98652017000400002 · Cited by 17
Lohse, Z., Knorr, S., Bytoft, B., Clausen, T. D., Jensen, R. B., Oturai, P., Beck‐Nielsen, H., Gravholt, C. H., Damm, P., Højlund, K., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4458-1 · Cited by 17
Koopman, A. D. M., Rutters, F., Rauh, S. P., Nijpels, G., Holst, J. J., Beulens, J. W. J., Alssema, M., & Dekker, J. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191114 · Cited by 17
Li, Y., Zhang, T., Han, T., Li, S., Bazzano, L., He, J., & Chen, W. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13259 · Cited by 17
Garg, P. K., Biggs, M. L., Kaplan, R. C., Kizer, J. R., Heckbert, S. R., & Mukamal, K. J. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.02.016 · Cited by 17
Hogling, D. E., Rydén, M., Bäckdahl, J., Thorell, A., Arner, P., & Andersson, D. P. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.03.012 · Cited by 15
Freitas, R. S., da Fonseca, M. D. J. M., Schmidt, M. I., Molina, M. D. C. B., & de Almeida, M. D. C. C. (2018) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00067617 · Cited by 18
Hübers, M., Geisler, C., Bosy‐Westphal, A., Braun, W., Pourhassan, M., Sørensen, T. I. A., & Müller, M. J. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0150-x · Cited by 18
Alvim, R. D. O., Zaniqueli, D. D. A., Neves, F. S., Pani, V. O., Martins, C. R., Peçanha, M. A. D. S., Barbosa, M. C. R., de Faria, E. R., & Mill, J. G. (2018) · Jornal de Pediatria · doi:10.1016/j.jped.2018.04.004 · Cited by 18
Physical fitness and activity, metabolic profile, adipokines and endothelial function in children
da Penha, J. T., Gazolla, F. M., Carvalho, C. N. D. M., Madeira, I. R., Rodrigues‐Júnior, F., Machado, E. D. A., Sicuro, F. L., Farinatti, P., Bouskela, E., & Collett‐Solberg, P. F. (2018) · Jornal de Pediatria · doi:10.1016/j.jped.2018.04.010 · Cited by 17
Association of Sensory Liking for Fat with Dietary Intake and Metabolic Syndrome in Korean Adults
Park, H.-Y., Shin, Y., Kwon, O., & Kim, Y. (2018) · Nutrients · doi:10.3390/nu10070877 · Cited by 18
Feng, R., Sun, G., Zhang, Y., Sun, Q., Ju, L., Sun, C., & Wang, C. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12828 · Cited by 17
Insulin resistance indexes in women with premature ovarian insufficiency — a pilot study
Kunicki, M., Rudnicka, E., Skórska, J., Calik-Ksepka, A., & Smolarczyk, R. (2018) · Ginekologia Polska · doi:10.5603/gp.a2018.0062 · Cited by 17
Huang, X., Liu, S., Wu, D., Cheng, Y., Han, H., Wang, K., Zhang, G., & Hu, S. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00274.2018 · Cited by 17
Adami, G. F., Camerini, G. B., Papadia, F. S., Catalano, M., Carlini, F., Cordera, R., & Scopinaro, N. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3511-6 · Cited by 17
Hwang, Y., Fujimoto, W. Y., Kahn, S. E., et al. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0053 · Cited by 17
Azizian, H., Khaksari, M., Asadikaram, G., Sepehri, G., & Najafipour, H. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.009 · Cited by 17
Tanaka, M., Honda, T., Yamakage, H., Hata, J., Yoshida, D., Hirakawa, Y., Shibata, M., Inoue, T., Kusakabe, T., Satoh‐Asahara, N., et al. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.10.007 · Cited by 17
Rynders, C. A., Pereira, R. I., Bergouignan, A., Kealey, E. H., & Bessesen, D. H. (2018) · Obesity · doi:10.1002/oby.22321 · Cited by 19
Sex Hormones and Measures of Kidney Function in the Diabetes Prevention Program Outcomes Study
Kim, C., Ricardo, A. C., Boyko, E. J., Christophi, C. A., Temprosa, M. G., Watson, K. E., Pi-Sunyer, X., & Kalyani, R. R. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01495 · Cited by 17
Central Nervous System and Peripheral Hormone Responses to a Meal in Children
Roth, C. L., Melhorn, S. J., Elfers, C., Scholz, K., Leon, M. R. B. D., Rowland, M. G., Kearns, S., Aylward, E., Grabowski, T. J., Saelens, B. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01525 · Cited by 17
Gür-Özmen, S. (2018) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.14744/semb.2018.09582 · Cited by 17
Watanabe, D., Kuranuki, S., Sunto, A., Matsumoto, N., & Nakamura, T. (2018) · Nutrients · doi:10.3390/nu10121834 · Cited by 17
Bombicz, M., Priksz, D., Gesztelyi, R., Kiss, R., Hollos, N., Varga, B., Németh, J., Tóth, A., Papp, Z., Szilvássy, Z., et al. (2019) · Molecules · doi:10.3390/molecules24030586 · Cited by 17
Oral glucose effectiveness and metabolic risk in obese children and adolescents
Spreghini, N., Cianfarani, S., Spreghini, M. R., Brufani, C., Morino, G. S., Inzaghi, E., Convertino, A., Fintini, D., & Manco, M. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01303-y · Cited by 17
Ebrahimpour‐Koujan, S., Sohrabpour, A. A., Foroughi, F., et al. (2019) · Trials · doi:10.1186/s13063-019-3241-7 · Cited by 17
Drexel, H., Leiherer, A., Saely, C. H., Brandtner, E. M., Geiger, K. D., Vonbank, A., Fraunberger, P., & Muendlein, A. (2019) · Bioscience Reports · doi:10.1042/bsr20190299 · Cited by 21
Seo, J. A., Lee, D. Y., Yu, J. H., Cho, H., Lee, S. K., Suh, S. A., Kim, S. G., Choi, K. M., Baik, S. H., Shin, C., et al. (2019) · SLEEP · doi:10.1093/sleep/zsz090 · Cited by 17
Fujihara, Y., Hamanoue, N., Yano, H., Tanabe, M., Akehi, Y., Nomiyama, T., & Yanase, T. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0505 · Cited by 18
Fruzzetti, F., Fidecicchi, T., Palla, G., & Gambacciani, M. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1640673 · Cited by 18
Yamauchi, T., Takasawa, K., Kamiya, T., Kirino, S., Gau, M., Inoue, K., Hoshino, A., Kashimada, K., Kanegane, H., & Morio, T. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12895 · Cited by 17
Jain, J., Gupta, N., Mathur, R., et al. (2019) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-019-00843-y · Cited by 17
Yarar‐Fisher, C., Li, J., McLain, A., Gower, B. A., Oster, R. A., & Morrow, C. D. (2019) · Trials · doi:10.1186/s13063-019-3520-3 · Cited by 17
Sjögren, M., Soylu-Kucharz, R., Dandunna, U., Stan, T. L., Cavalera, M., Sandelius, Å., Zetterberg, H., & Björkqvist, M. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104560 · Cited by 17
Liang, Z., Wang, L., Liu, H., Chen, Y., Zhou, T., Heianza, Y., Leng, J., Li, W., Yang, X., Shen, Y., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.08.032 · Cited by 20
Zhang, W., Huang, R., Wang, Y., Rao, H., Wei, L., Su, G. L., & Lok, A. S.-F. (2019) · Hepatology Communications · doi:10.1002/hep4.1435 · Cited by 17
Machado, M. V., Policarpo, S., Coutinho, J. R. H., Carvalhana, S. C., Leitão, J., Carvalho, A. D. M., Silva, A. P., Velasco, F., Medeiros, I., Alves, A. C., et al. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04213-8 · Cited by 18
Quintana‐Castro, R., Aguirre-Maldonado, I., Soto-Rodríguez, I., Lago, R. A. D., Gruber-Pagola, P., de Larrea, Y. K. U., Juárez-Rivera, V. E., Ramos-Manuel, L. E., & Alexander-Aguilera, A. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106404 · Cited by 18
Roche, J., Corgosinho, F. C., Dâmaso, A. R., Isacco, L., Miguet, M., Fillon, A., Guyon, A., Moreira, G. A., Pradella-Hallinan, M. L. D. C., Tufik, S., et al. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.12.003 · Cited by 17
Hogling, D. E., Bäckdahl, J., Thorell, A., Rydén, M., & Andersson, D. P. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04304-6 · Cited by 17
Ilex paraguariensis , white mulberry and chromium picolinate in patients with pre‐diabetes
Derosa, G., D’Angelo, A., & Maffioli, P. (2020) · Phytotherapy Research · doi:10.1002/ptr.6611 · Cited by 19
Impact of age, body weight and metabolic risk factors on steroid reference intervals in men
Mezzullo, M., Dalmazi, G. D., Fazzini, A., Baccini, M., Repaci, A., Gambineri, A., Vicennati, V., Pelusi, C., Pagotto, U., & Fanelli, F. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0928 · Cited by 17
Schwenger, K. J. P., Ghorbani, Y., Li, C., Fischer, S. E., Jackson, T. D., Okrainec, A., & Allard, J. P. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04514-3 · Cited by 17
TRI-PONDERAL MASS INDEX IS USEFUL FOR SCREENING CHILDREN AND ADOLESCENTS WITH INSULIN RESISTANCE
Neves, F. S., Alvim, R. D. O., Zaniqueli, D., Pani, V. O., Martins, C. R., Peçanha, M. A. D. S., Barbosa, M., de Faria, E. D., & Mill, J. (2020) · Revista Paulista de Pediatria · doi:10.1590/1984-0462/2020/38/2019066 · Cited by 15
Yoon, S., Lee, H., Ji, S., Yoon, S. H., Cho, J., & Chung, J. (2020) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.790 · Cited by 18
Demir, İ., & Güler, A. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1751109 · Cited by 17
Yoshinaga, M., Miyazaki, A., Aoki, M., Ogata, H., Ito, Y., Hamajima, T., Tokuda, M., Lin, L., Horigome, H., Takahashi, H., et al. (2020) · Pediatrics International · doi:10.1111/ped.14253 · Cited by 17
Hussein, A. M., Eid, E. A., Bin‐Jaliah, I., Taha, M., & Lashin, L. S. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200420084444 · Cited by 17
The importance of maternal insulin resistance throughout pregnancy on neonatal adiposity
Lima, R. A., Desoyé, G., Simmons, D. S., Devlieger, R., Galjaard, S., Corcoy, R., Adelantado, J. M., Dunne, F., Harreiter, J., Kautzky‐Willer, A., et al. (2020) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12682 · Cited by 19
Noordam, R., Boersma, V., Verkouter, I., le Cessie, S., Christen, T., Lamb, H. J., Rosendaal, F. R., van Dijk, K. W., van Heemst, D., & de Mutsert, R. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.04.021 · Cited by 17
Association between Abdominal Fat Distribution and Free Triiodothyronine in a Euthyroid Population
Nie, X., Xu, Y., Ma, X., Xiao, Y., Wang, Y., & Bao, Y. (2020) · Obesity Facts · doi:10.1159/000507709 · Cited by 17
Chynoweth, J., Hosking, J., Jeffery, A., & Pinkney, J. H. (2020) · Pediatric Obesity · doi:10.1111/ijpo.12685 · Cited by 17
Circulating microRNAs associated with C-type natriuretic peptide in childhood obesity
Cabiati, M., Randazzo, E., Salvadori, C., et al. (2020) · Peptides · doi:10.1016/j.peptides.2020.170387 · Cited by 17
Yang, T. Y., Gao, Z., & Liang, N. (2020) · Nutrients · doi:10.3390/nu12092721 · Cited by 18
Sasaki, N., Ozono, R., Maeda, R., & Higashi, Y. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001500 · Cited by 17
Associations of Sedentary Patterns with Cardiometabolic Biomarkers in Physically Active Young Males
Zheng, C., Tian, X. Y., Sun, F., Huang, Y., Sheridan, S. E., Wu, Y., & Wong, S. H. (2020) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002528 · Cited by 17
Morbidly obese subjects show increased serum sulfide in proportion to fat mass
Comas, F., Latorre, J., Ortega, F. J., Arnoriaga‐Rodríguez, M., Lluch, A., Sabater, M., Rius, F., Ribas, X., Costas, M., Ricart, W., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-00696-z · Cited by 17
Wang, Q., Zhao, Y., Wang, X., Ji, X., Sang, S., Shao, S., Ma, X., Wang, G., Lv, M., Xue, F., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001788 · Cited by 17
Kamal, M. M., Adel, A., Sayed, G. H., Ragab, S. H., & Kassem, D. H. (2020) · Translational research · doi:10.1016/j.trsl.2020.12.004 · Cited by 17
Stentz, F. B., Mikhael, A., Kineish, O., Christman, J. V., & Sands, C. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.11.027 · Cited by 21
Li, M., Cui, Z., Meng, S., Li, T., Kang, T., Ye, Q., Cao, M., Bi, Y., & Meng, H. (2020) · Nutrients · doi:10.3390/nu13010116 · Cited by 18
Lahelma, M., Luukkonen, P. K., Qadri, S. U., Ahlholm, N., Lallukka-Brück, S. E., Porthan, K., Juuti, A., Sammalkorpi, H. E., Penttilä, A. K., Arola, J. T., et al. (2021) · Nutrients · doi:10.3390/nu13010169 · Cited by 18
Homeostasis model assessment, serum insulin and their relation to body fat in cats
Strage, E. M., Ley, C. J., Forkman, J., et al. (2021) · BMC Veterinary Research · doi:10.1186/s12917-020-02729-1 · Cited by 17
Arija, S. M., Vázquez, N. M., Garnica, I. U., Rioja, J., Valdivielso, P., Ginel-Mendoza, L., Abad-Sánchez, S., Jiménez-Núñez, F. G., Oliver‐Martos, B., & Fernández‐Nebro, A. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044749 · Cited by 17
Song, X., Wang, H., Su, C., Wang, Z., Huang, F., Zhang, J., Du, W., Jia, X., Jiang, H., Ouyang, Y., et al. (2021) · Nutrients · doi:10.3390/nu13030725 · Cited by 18
Huang, H.-B., Siao, C.-Y., Lo, Y. C., Shih, S., Lu, C., & Huang, P. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.116799 · Cited by 18
Kouda, K., Fujita, Y., Ohara, K., Tachiki, T., Tamaki, J., Yura, A., Moon, J., Kajita, E., Uenishi, K., & Iki, M. (2021) · Environmental Health and Preventive Medicine · doi:10.1186/s12199-021-00959-9 · Cited by 17
di Palumbo, A. S., McSwiney, F. T., Hone, M., McMorrow, A. M., Lynch, G. M., VITO, G. D., & Egan, B. (2021) · Journal of Dietary Supplements · doi:10.1080/19390211.2021.1897057 · Cited by 17
Postprandial dynamics and response of fibroblast growth factor 21 in older adults
Herpich, C., Haß, U., Kochlik, B., Franz, K., Laeger, T., Klaus, S., Bosy‐Westphal, A., & Norman, K. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.04.037 · Cited by 17
Rizk, N. M., Fadel, A., AlShammari, W., Younes, N., & Bashah, M. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s282189 · Cited by 20
Akbarian, F., Rahmani, M., Tavalaee, M., Abedpoor, N., Taki, M., Ghaedi, K., & Nasr‐Esfahani, M. H. (2021) · PubMed Central · doi:10.22074/ijfs.2021.137231.1022 · Cited by 17
Calcaterra, V., Bosoni, P., Dilillo, D., et al. (2021) · Children · doi:10.3390/children8050384 · Cited by 17
Costa, J. S. R., Fonseca, G. F. A. C., Ottone, N. C. D. S., Silva, P. A., Antonaccio, R. F., Silva, G., Rocha, M. D. S. A., Coimbra, C. C., Esteves, E. A., Mang, Z. A., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119639 · Cited by 19
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
